Graceway Files Litigation Against River’s Edge

Graceway Pharmaceuticals, LLC (“Graceway”) today announced that it yesterday filed a lawsuit against River’s Edge Pharmaceuticals, LLC (“River’s Edge”) in the United States District Court for the Northern District of Georgia based on River’s Edge’s improper sales and marketing practices.

The lawsuit alleges that River’s Edge unlawfully promotes its benzoyl peroxide gel and wash products as generically equivalent to – or otherwise substitutable for – Graceway’s BenziqTM family of products: Benziq LS Gel (benzoyl peroxide 2.75%); Benziq Gel 50 g Tube (benzoyl peroxide 5.25%); and Benziq Wash (benzoyl peroxide 5.25%) (collectively “Benziq”). The lawsuit sets forth claims for False Advertising and Unfair Competition in violation of the federal Lanham Act, as well as claims for common law Unfair Competition and Misappropriation.

Benziq is available by prescription only, and was created for patients with a preference for a hydrating benzoyl peroxide treatment that does not irritate the skin.

Indication:
Benziq is indicated for the topical treatment of acne vulgaris.

Safety Information:
Allergic contact dermatitis and dryness have been reported with topical benzoyl peroxide therapy. If severe irritation develops, discontinue use and institute appropriate therapy. After reaction clears, treatment may often be resumed with less frequent application.

About Graceway Pharmaceuticals, LLC
Graceway Pharmaceuticals, LLC, headquartered in Bristol, TN, is a pharmaceutical company focused on acquiring, in-licensing, and developing branded prescription pharmaceutical products. Current prescription products marketed by Graceway include ALDARA® (imiquimod) Cream 5%, Maxair® Autohaler® (pirbuterol acetate inhalation aerosol), Atopiclair® Nonsteroidal Cream, BenziqTM (benzoyl peroxide), and Estrasorb® (estrodiol topical emulsion). ALDARA®, Maxair®, Autohaler®, Atopiclair®, BenziqTM, and Estrasorb® are trademarks owned by or licensed to Graceway. For more information on Graceway’s products, including important safety information, please visit www.GracewayPharma.com.

Contact:
Graceway Pharmaceuticals, LLC
John Bellamy
Executive Vice President & General Counsel
(423) 274-2100

Leave a Reply

Your email address will not be published. Required fields are marked *